TH103 showed mean 10-letter gain in visual acuity and rapid, robust anatomic improvement at Month 1, following a single injectionTH103 was ...

SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular AMD across all GA lesion types at 1 ...

BCVA is inadequate for detecting visual disturbances in conditions like MacTel, which initially affect the parafoveal region.

UFC heavyweught champion Tom Aspinall provides his medical diagnosis on the eye injury he sustained in his title defense at ...

PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block endothelin signaling to increase ocular blood flow and prevent vision loss. A ...

Please provide your email address to receive an email when new articles are posted on . A study compared the optical and refractive performance of an enhanced monofocal IOL vs. an aberration-free ...

EZ-RPE CST is a precursor to future visual loss, with thinner CSTs indicating greater risk. Baseline EZ integrity correlates with visual acuity changes over time in GA patients. Eyes with more severe ...

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews. The current claims should be better supported by more evidence.

Background/aims To determine a cluster of test points: visual subfield (VSF) of Humphrey Field Analyzer 10–2 test (HFA 10–2) of which baseline sensitivities were associated with future worsening of ...

Introduction: There is no established acute intervention for central retinal artery occlusion (CRAO) which often results in poor visual outcomes. Intravenous Alteplase (tPA) has emerged as a promising ...

Hello, and thank you for joining us to discuss Belite Bio's Third Quarter 2024 Financial Results. Joining the call today are Dr. Tom Lin, Chairman and CEO of Belite Bio; Dr. Hendrik Scholl, Chief ...